Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A bioartificial 3D bronchial epithelial airway model to study lunar hay fever on Earth.

Trends in biotechnology·2026
Same author

An optically accessible two-chamber perfusion bioreactor for label-free metabolic imaging of three-dimensional tissue models under dynamic flow conditions.

Biomedical materials (Bristol, England)·2026
Same author

An intestinal matrix-based human lung cancer model reflects clinical data from gefitinib on dosage-dependent efficacy.

Toxicology and applied pharmacology·2025
Same author

Modular Ti-6Al-4V system for <i>in vitro</i> optimization of implant materials.

Frontiers in bioengineering and biotechnology·2025
Same author

Biomimetic hydrogel scaffolds for stimulating fibrotic responses: development of an in-vitro assay for implant material testing.

Frontiers in bioengineering and biotechnology·2025
Same author

Developing human upper, lower, and deep lung airway models: Combining different scaffolds and developing complex co-cultures.

Journal of tissue engineering·2025

Related Experiment Video

Updated: May 20, 2026

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

Upcyte® microvascular endothelial cells repopulate decellularized scaffold.

Katharina Scheller1, Iris Dally, Nadja Hartmann

  • 1Medicyte GmbH, Heidelberg, Germany. k.scheller@medicyte.com

Tissue Engineering. Part C, Methods
|July 18, 2012
PubMed
Summary
This summary is machine-generated.

Researchers developed a novel vascularization model using upcyte microvascular endothelial cells (mvECs) and a biological vascularized scaffold (BioVaSc). This approach overcomes limitations in cell supply and differentiation, promising improved tissue engineering and organoid development.

More Related Videos

Decellularization and Recellularization of Whole Livers
09:24

Decellularization and Recellularization of Whole Livers

Published on: February 4, 2011

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies
08:10

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies

Published on: March 21, 2019

Related Experiment Videos

Last Updated: May 20, 2026

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

Decellularization and Recellularization of Whole Livers
09:24

Decellularization and Recellularization of Whole Livers

Published on: February 4, 2011

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies
08:10

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies

Published on: March 21, 2019

Area of Science:

  • Tissue Engineering
  • Biotechnology
  • Regenerative Medicine

Background:

  • Poor blood supply is a major hurdle in tissue engineering, limiting cell survival and function.
  • Existing microvascular endothelial cell (mvEC) sources are limited and prone to dedifferentiation.
  • A novel technology enables the generation of large batches of quasi-primary cells (upcyte mvECs) that maintain differentiated functionality.

Purpose of the Study:

  • To develop an in vitro vascularization model using upcyte mvECs and a biological vascularized scaffold (BioVaSc).
  • To assess the proliferation, differentiation, and functionality of upcyte mvECs within the BioVaSc model.
  • To evaluate the potential of this combined approach for creating vascularized bioreactor models.

Main Methods:

  • A decellularized porcine small bowel segment (BioVaSc) was reseeded with upcyte mvECs.
  • Upcyte mvECs were characterized for endothelial markers (vWF, CD31, eNOS) and functionality (tube formation, migration, LDL uptake) up to population doubling 27 (PD27).
  • Upcyte mvECs were cultured within the BioVaSc in a custom bioreactor for 14 days and assessed for cell survival and marker expression.

Main Results:

  • Upcyte mvECs proliferated for an additional 15 population doublings compared to primary cells.
  • Upcyte mvECs retained key endothelial characteristics and biological functions up to PD27.
  • Cells successfully repopulated the BioVaSc scaffold and maintained endothelial marker expression in a bioreactor for 14 days.

Conclusions:

  • The combination of upcyte mvECs and the BioVaSc scaffold represents a promising strategy for in vitro vascularization.
  • This approach addresses limitations in endothelial cell supply and maintenance of function.
  • The developed model holds potential for creating more physiologically relevant vascularized bioreactor systems for applications like liver tissue engineering.